Remote ischemic conditioning for acute respiratory distress syndrome in COVID-19

Acute respiratory distress syndrome and subsequent respiratory failure remains the leading cause of death (>80%) in patients severely impacted by COVID-19. The lack of clinically effective therapies for COVID-19 calls for the consideration of novel adjunct therapeutic approaches. Though novel ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Incognito, Anthony V., Millar, Philip J., Pyle, W. Glen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Physiological Society 2021
Materias:
Mini-Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938644/
https://www.ncbi.nlm.nih.gov/pubmed/33404365
http://dx.doi.org/10.1152/ajplung.00223.2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938644/
https://www.ncbi.nlm.nih.gov/pubmed/33404365
http://dx.doi.org/10.1152/ajplung.00223.2020

Ejemplares similares